investors to better understand the Company and its subsidiaries’ 2nd quarter of 2019 reviewed financial statements. An Analysis of Performance * Analysis of Income The Company and its subsidiaries recorded
investors to better understand the Company and its subsidiaries’ 2nd quarter of 2018 reviewed financial statements. An Analysis of Performance * Analysis of Income The Company and its subsidiaries recorded
investors to better understand the Company and its subsidiaries’ 3rd quarter of 2018 reviewed financial statements. An Analysis of Performance * Analysis of Income The Company and its subsidiaries recorded
investors to better understand the Company and its subsidiaries’ 3rd quarter of 2019 reviewed financial statements. An Analysis of Performance * Analysis of Income The Company and its subsidiaries recorded
investors to better understand the Company and its subsidiary’s 1st quarter of 2020 reviewed financial statements. An Analysis of Performance * Analysis of Income The Company and its subsidiary recorded the
% 7.4% 12.2% 6.7% 8.2% % NNP - Owner of the parent 63.1% 63.6% 64.2% 64.5% 62.9% Remark: * EBITDA = Earnings before Interest, Taxes, Depreciation and Amortization - Non-recurring income / (expense
period last year (Q2/2016 : THB 113.09 million). As a result of an increase in OPD patients volume, revenue from hospital operations in Q2/2017 was THB 116.53 million, an increased by THB 5.29 million or
18.09 million baht or equivalent to 10.83% in comparison with previous years, which was the result form sales decrease. However, cost of goods sales to revenue ratio decreased 51.24% from previous year to
. Mainly by the increasing of Revenue from sales 7% with the increasing from sales price and sales volume. There are gross profit rate for the second quarter is 18%, and 10 % in the second quarter of 2018
Million Baht. Mainly by the increasing of Revenue from sales 10% with the increasing from sales price and sales volume. There are gross profit rate for the third quarter is 21%, and 14 % in the third